Cost-Effectiveness of Proton Versus Photon Therapy for Medulloblastoma Using Updated Clinical Outcomes
Despite its higher cost, PBT was more cost-effective than XRT for treating medulloblastoma in a middle-income country, based on updated clinical outcomes, particularly when incorporating IQ decline into the analysis.
Authors
- Anussara Prayongrat (ORCID: https://orcid.org/0000-0002-0977-8316)
- Maythinee Chantadisai (ORCID: https://orcid.org/0000-0003-1691-3958)
- Piti Techavichit (ORCID: https://orcid.org/0000-0002-1888-1446)
- Kanjana Shotelersuk (ORCID: https://orcid.org/0000-0002-8714-5733)
- Chonnipa Nantavithya (ORCID: https://orcid.org/0000-0002-3744-0830)
- Nattawan Utoomprurkporn (ORCID: https://orcid.org/0000-0001-6472-7573)
- Wasin Laohavinij
- Khomsak Srilanchakon (ORCID: https://orcid.org/0009-0007-2017-7830)
- Chaisiri Wanlapakorn
Institutions
- Thai Red Cross Society (TH)
- Chulalongkorn University (TH)
- King Chulalongkorn Memorial Hospital (TH)
Publication Details
- Journal
- International Journal of Particle Therapy
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1016/j.ijpt.2025.100754
- Citations
- 2
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 3.04